CompletedNot Applicable

Effect of Upper-body Rowing on Cardiometabolic Risk in Spinal Cord Injured Wheelchair Users

Denmark18 participantsStarted 2021-01-11

Plain-language summary

This randomized controlled trial will determine the effects of 12-weeks of wheelchair user-modified upper-body rowing on both traditional cardiometabolic risk factors in SCI manual wheelchair users.

Who can participate

Age range18 Years – 65 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * 18-65 years; * chronic SCI (≥1 year since injury) * individuals with sufficient sparing of arm function to participate in upper-body rowing (i.e. as a minimum excluding individuals with complete SCI at or above C5) * using a manual wheelchair as a primary tool for mobility. Exclusion Criteria: * Individuals who regularly engage in \>150 min/week of moderate-to-vigorous intensity physical activity * have received a cortisone injection in the shoulder within the last four months * have had shoulder injury within the previous year * known medical issues (urinary tract infections, cardiovascular contraindications for exercise testing, and pressure sores) * diagnosed diabetes or any endocrine, heart, kidney, liver disease or any other disease that may limit the ability to perform exercise.

What they're measuring

fasting insulin

Timeframe: The between group difference in change in outcome will be examined from baseline to post intervention (12-weeks follow-up) (primary endpoint) and again from 12-weeks follow-up to 6-months follow-up (secondary endpoint)

Trial details

NCT IDNCT04390087

SponsorAalborg University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2021-11-25

View on ClinicalTrials.gov More Spinal Cord Injuries trials